Akebia Therapeutics Inc (AKBA)
1.335
0.00 (0.00%)
USD |
NASDAQ |
Apr 26, 16:00
1.335
0.00 (0.00%)
After-Hours: 20:00
Akebia Therapeutics Market Cap: 279.51M for April 26, 2024
Market Cap Chart
Historical Market Cap Data
Date | Value |
---|---|
April 25, 2024 | 278.47M |
April 24, 2024 | 286.84M |
April 23, 2024 | 286.84M |
April 22, 2024 | 284.75M |
April 19, 2024 | 284.75M |
April 18, 2024 | 291.03M |
April 17, 2024 | 291.03M |
April 16, 2024 | 293.12M |
April 15, 2024 | 291.03M |
April 12, 2024 | 305.68M |
April 11, 2024 | 320.34M |
April 10, 2024 | 326.62M |
April 09, 2024 | 322.43M |
April 08, 2024 | 320.34M |
April 05, 2024 | 311.96M |
April 04, 2024 | 316.15M |
April 03, 2024 | 311.96M |
April 02, 2024 | 330.81M |
April 01, 2024 | 341.28M |
March 28, 2024 | 383.15M |
March 27, 2024 | 468.99M |
March 26, 2024 | 418.74M |
March 25, 2024 | 462.71M |
March 22, 2024 | 454.34M |
March 21, 2024 | 427.12M |
Date | Value |
---|---|
March 20, 2024 | 406.18M |
March 19, 2024 | 383.15M |
March 18, 2024 | 395.71M |
March 15, 2024 | 355.93M |
March 14, 2024 | 286.84M |
March 13, 2024 | 295.21M |
March 12, 2024 | 276.31M |
March 11, 2024 | 280.20M |
March 08, 2024 | 286.04M |
March 07, 2024 | 284.09M |
March 06, 2024 | 289.93M |
March 05, 2024 | 311.33M |
March 04, 2024 | 315.22M |
March 01, 2024 | 332.74M |
February 29, 2024 | 307.44M |
February 28, 2024 | 299.66M |
February 27, 2024 | 319.12M |
February 26, 2024 | 293.82M |
February 23, 2024 | 262.69M |
February 22, 2024 | 270.47M |
February 21, 2024 | 276.31M |
February 20, 2024 | 280.20M |
February 16, 2024 | 282.14M |
February 15, 2024 | 286.04M |
February 14, 2024 | 297.71M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
45.99M
Minimum
Nov 29 2022
1.944B
Maximum
Jun 30 2020
469.42M
Average
424.13M
Median
Aug 16 2021
Market Cap Benchmarks
Ocugen Inc | 326.80M |
Aquestive Therapeutics Inc | 298.70M |
SELLAS Life Sciences Group Inc | 81.87M |
Protagonist Therapeutics Inc | 1.463B |
Stoke Therapeutics Inc | 573.70M |
Market Cap Related Metrics
PS Ratio | 1.285 |
Price | 1.335 |
Earnings Yield | -20.97% |